# Editorial: Bringing function to the forefront of cell therapy: how do we demonstrate potency?

**Authors:** Alasdair R. Fraser, Stuart M. Curbishley, Andy Roemhild, Kwong Tsang

PMC · DOI: 10.3389/fimmu.2024.1472727 · 2024-08-12

## Full-text entities

- **Genes:** IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CXADRP1 (CXADR pseudogene 1) [NCBI Gene 653108] {aka CAR, CXADRP}
- **Diseases:** severe COVID (MESH:D045169), COVID (MESH:D000086382), inflammatory damage (MESH:D018746), EBV (MESH:D020031), Tumour (MESH:D009369), cytotoxicity (MESH:D064420)
- **Chemicals:** PS (MESH:D010718), dexamethasone (MESH:D003907), ATMP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11345548